This research used a genome-wide association study to look for genetic variations in people with Tourette Syndrome and tic disorders. The team examined DNA from 13,247 individuals with these conditions and compared it to 536,217 people without them. They focused on participants of European ancestry to identify independent genetic locations that increase risk.
The analysis found six independent genetic locations significantly linked to the disorders. Researchers also noticed a shared genetic signal at a specific spot on chromosome 3 that connects Tourette Syndrome with attention-deficit/hyperactivity disorder. Through gene prioritization, they highlighted 20 specific genes, including PCDH9 and HCN1, that may play a role in these conditions.
Further analysis showed that genetic risk is associated with specific brain cells, such as dopamine receptor-positive neurons and cortical pyramidal neurons. The study found extensive genetic connections with other neurodevelopmental and psychiatric traits, but no links to general neurological disorders. While these findings offer insight into the biological underpinnings of tic disorders, they are observational and do not prove that these genes directly cause the symptoms.
Readers should understand that this study identifies potential biological pathways but does not provide a cure or a new treatment. The results are important for understanding the condition's complexity, but they should not be used to diagnose individuals or change current medical care. More research is needed to translate these genetic findings into practical applications for patients.